Racial differences in cerebral vasospasm: A systematic review of the literature

Neurosurgery

Volumn 58, Issue 2, 2006, Pages 305-312

  Mocco, J ^a   Ransom, Evan R ^a   Komotar, Ricardo J ^a   Mack, William J ^a   Sergot, Paulina B ^a   Albert, Steven M ^a   Connolly Jr , E Sander ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Aneurysm; Race; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

BRAIN ANGIOGRAPHY; BRAIN INFARCTION; BRAIN VASOSPASM; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; EUROPE; HUMAN; INCIDENCE; JAPAN; MEDICAL LITERATURE; MEDLINE; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; PUBLICATION; RACE DIFFERENCE; RADIODIAGNOSIS; REVIEW; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE; SYSTEMATIC REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; CONTINENTAL POPULATION GROUPS; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; NORTH AMERICA; RISK FACTORS; VARIATION (GENETICS); VASOSPASM, INTRACRANIAL;

EID: 32244448190     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000195009.02412.E8     Document Type: Review

References (73)

1. Adams HP Jr, Kassell NF, Torner JC, Nibbelink DW, Sahs AL: Early management of aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 54:141-145, 1981.
2. Albrecht EW, Stegeman CA, Heeringa P, Henning RH, van Goor H: Protective role of endothelial nitric oxide synthase. J Pathol 199:8-17, 2003.
3. Asano T, Takakura K, Sano K, Kikuchi H, Nagai H, Saito I, Tamura A, Ochiai C, Sasaki T: Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double-blind trial. J Neurosurg 84:792-803, 1996.
4. Beltrame JF, Sasayama S, Maseri A: Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 33:1442-1452, 1999.
5. CIA World Factbook. Available at http://www.statcan.ca/english/Pgdb/ popula.htm. Accessed March 22, 2005.
6. Claassen J, Bernardini GL, Kreiter K, Bates J, Du YE, Copeland D, Connolly ES Jr, Mayer SA: Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: The Fisher scale revisited. Stroke 32:2012-2020, 2001.
7. Creissard P, Proust F, Langlois O: Vasospasm diagnosis: Theoretical and real transcranial Doppler sensitivity. Acta Neurochir (Wien) 136:181-185, 1995.
8. Dehdashti AR, Mermillod B, Rufenacht DA, Reverdin A, de Tribolet N: Does treatment modality of intracranial ruptured aneurysms influence the incidence of cerebral vasospasm and clinical outcome? Cerebrovasc Dis 17:53-60, 2004.
9. Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS: Cerebral vasospasm after subarachnoid hemorrhage: Putative role of inflammation. Neurosurgery 53:123-133, 2003.
10. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R: Serial changes of hemostasis in aneurysmal subarachnoid hemorrhage with special reference to delayed ischemic neurological deficits. J Neurosurg 86:594-602, 1997.
11. Goddard AJ, Raju PP, Gholkar A: Does the method of treatment of acutely ruptured intracranial aneurysms influence the incidence and duration of cerebral vasospasm and clinical outcome? J Neurol Neurosurg Psychiatry 75:868-872, 2004.
12. Grosset DG, Straiton J, McDonald I, Bullock R: Angiographic and Doppler diagnosis of cerebral artery vasospasm following subarachnoid haemorrhage. Br J Neurosurg 7:291-298, 1993.
13. Gruber A, Ungersbock K, Reinprecht A, Czech T, Gross C, Bednar M, Richling B: Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms. Neurosurgery 42:258-267, 1998.
14. Hamada J, Kai Y, Morioka M, Yano S, Mizuno T, Hirano T, Kazekawa K, Ushio Y: Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: A prospective randomized study. Stroke 34:2549-2554, 2003.
15. Hirashima Y, Endo S, Kurimoto M, Tsukamoto E, Takaku A: Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage. Acta Neurochir (Wien) 128:144-149, 1994.
16. Ikeda K, Ikeda T, Onizuka T, Terashi H, Fukuda T: C-type natriuretic peptide concentrations in the plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage. Crit Care 5:37-40, 2001.
17. Inagawa T, Kamiya K, Matsuda Y: Effect of continuous cisternal drainage on cerebral vasospasm. Acta Neurochir (Wien) 112:28-36, 1991.
18. Inagawa T, Yamamoto M, Kamiya K: Effect of clot removal on cerebral vasospasm. J Neurosurg 72:224-230, 1990.
19. Jarus-Dziedzic K, Juniewicz H, Wronski J, Zub WL, Kasper E, Gowacki M, Mierzwa J: The relation between cerebral blood flow velocities as measured by TCD and the incidence of delayed ischemic deficits. A prospective study after subarachnoid hemorrhage. Neurol Res 24:582-592, 2002.
20. Juvela S, Hillbom M, Kaste M: Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg 74:386-392, 1991.
21. Khurana VG, Smith LA, Weiler DA, Springett MJ, Parisi JE, Meyer FB, Marsh WR, O'Brien T, Katusic ZS: Adenovirus-mediated gene transfer to human cerebral arteries. J Cereb Blood Flow Metab 20:1360-1371, 2000.
22. Khurana VG, Sohni YR, Mangrum WI, McClelland RL, O'Kane DJ, Meyer FB, Meissner I: Endothelial nitric oxide synthase gene polymorphisms predict susceptibility to aneurysmal subarachnoid hemorrhage and cerebral vasospasm. J Cereb Blood Flow Metab 24:291-297, 2004.
23. Kilic T, Pamir MN, Ozek MM, Zirh T, Erzen C: A new, more dependable methodology for the use of transcranial Doppler ultrasonography in the management of subarachnoid haemorrhage. Acta Neurochir (Wien) 138: 1070-1078, 1996.
24. Kotani K, Shimomura T, Murakami F, Ikawa S, Kanaoka Y, Ohgi S, Adachi K, Nanba E: Allele frequency of human endothelial nitric oxide synthase gene polymorphism in abdominal aortic aneurysm. Intern Med 39:537-539, 2000.
25. Kotsopoulos IA, van Merode T, Kessels FG, de Krom MC, Knottnerus JA: Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 43:1402-1409, 2002.
26. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 88:4651-4655, 1991.
27. Lasner TM, Weil RJ, Riina HA, King JT Jr, Zager EL, Raps EC, Flamm ES: Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 87:381-384, 1997.
28. Laumer R, Steinmeier R, Gonner F, Vogtmann T, Priem R, Fahlbusch R: Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 1. Reliability of flow velocities in clinical management. Neurosurgery 33:1-9, 1993.
29. Laycock SK, Vogel T, Forfia PR, Tuzman J, Xu X, Ochoa M, Thompson CI, Nasjletti A, Hintze TH: Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 82:1263-1271, 1998.
30. Lee PC, Salyapongse AN, Bragdon GA, Shears LL 2nd, Watkins SC, Edington HD, Billiar TR: Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 277:H1600-H1608, 1999.
31. Lembo G, De Luca N, Battagli C, Iovino G, Aretini A, Musicco M, Frati G, Pompeo F, Vecchione C, Trimarco B: A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32:735-740, 2001.
32. Lindegaard KF: The role of transcranial Doppler in the management of patients with subarachnoid haemorrhage - A review. Acta Neurochir Suppl (Wien) 72:59-71, 1999.
33. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr: Ventriculostomy- related infections: A critical review of the literature. Neurosurgery 51:170-181, 2002.
34. Macdonald RL, Rosengart A, Huo D, Karrison T: Factors associated with the development of vasospasm after planned surgical treatment of aneurysmal subarachnoid hemorrhage. J Neurosurg 99:644-652, 2003.
35. Maseri A, Chierchia S: Coronary artery spasm: Demonstration, definition, diagnosis, and consequences. Prog Cardiovasc Dis 25:169-192, 1982.
36. Microsoft Encarta Encyclopedia. Available at http://encarta.msn.com/ . Accessed March 22, 2005.
37. Miyaoka M, Sato K, Ishii S: A clinical study of the relationship of timing to outcome of surgery for ruptured cerebral aneurysms. A retrospective analysis of 1622 cases. J Neurosurg 79:373-378, 1993.
38. Mori K, Arai H, Nakajima K, Tajima A, Maeda M: Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 26:1620-1626, 1995.
39. Morris JA, Gardner MJ: Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J (Clin Res Ed) 296:1313-1316, 1988.
40. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K: T-786->C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864-2870, 1999.
41. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Ogawa H, Kugiyama K, Mizuno Y, Harada E, Nakamura S, Ito T, Saito Y, Miyamoto Y, Ogawa Y, Nakao K: T(-786)-> C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol 86:628-634, 2000.
42. Nassar BA, Bevin LD, Johnstone DE, O'Neill BJ, Bata IR, Kirkland SA, Title LM: Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease. Am Heart J 142:586-589, 2001.
43. Ohkuma H, Suzuki S, Kudo K, Islam S, Kikkawa T: Cortical blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Three-dimensional N-isopropyl-p-[(123)I]iodoamphetamine single photon emission CT findings. AJNR Am J Neuroradiol 24:444-450, 2003.
44. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526, 1987.
45. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A: Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation 101:1102-1108, 2000.
46. Proust F, Callonec F, Clavier E, Lestrat JP, Hannequin D, Thiebot J, Freger P: Usefulness of transcranial color-coded sonography in the diagnosis of cerebral vasospasm. Stroke 30:1091-1098, 1999.
47. Proust F, Hannequin D, Langlois O, Freger P, Creissard P: Causes of morbidity and mortality after ruptured aneurysm surgery in a series of 230 patients. The importance of control angiography. Stroke 26:1553-1557, 1995.
48. Rabb CH, Tang G, Chin LS, Giannotta SL: A statistical analysis of factors related to symptomatic cerebral vasospasm. Acta Neurochir (Wien) 127:27-31, 1994.
49. Radomski MW, Palmer RM, Moncada S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057-1058, 1987.
50. Ratliff JK, Cooper PR: Cervical laminoplasty: A critical review. J Neurosurg Spine 98:230-238, 2003.
51. Sakaguchi J, Takeshita M, Kagawa M, Izawa M, Takakura K: HLA-type of cerebral vasospasm patients after aneurysmal subarachnoid hemorrhage. Neurosurg Rev 17:67-71, 1994.
52. Sander M, Chavoshan B, Victor RG: A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33:937-942, 1999.
53. Sasayama S: How to study the prevalence and mechanisms of racial differences in coronary vasomotor response. Ital Heart J 3:237-240, 2002.
54. Säveland H, Hillman J, Brandt L, Edner G, Jakobsson KE, Algers G: Overall outcome in aneurysmal subarachnoid hemorrhage. A prospective study from neurosurgical units in Sweden during a 1-year period. J Neurosurg 76:729-734, 1992.
55. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM: Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Effects on cell proliferation. Circ Res 71:1088-1100, 1992.
56. Shaw MD, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM: Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: A report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group. J Neurosurg 93:992-997, 2000.
57. Shibuya M, Suzuki Y, Enomoto H, Okada T, Ogura K, Sugita K: Effects of prophylactic intrathecal administrations of nicardipine on vasospasm in patients with severe aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 131:19-25, 1994.
58. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:571-577, 1992.
59. Shimoda M, Takeuchi M, Tominaga J, Oda S, Kumasaka A, Tsugane R: Asymptomatic versus symptomatic intarcts from vasospasm in patients with subarachnoid hemorrhage: Serial magnetic resonance imaging. Neurosurgery 49:1341-1350, 2001.
60. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, Hernesniemi JA, Lassila R: No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled clinical trial. J Neurosurg 99:953-959, 2003.
61. Stangl K, Cascorbi I, Laule M, Klein T, Stangl V, Rost S, Wernecke KD, Felix SB, Bindereif A, Baumann G, Roots I: High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. Pharmacogenetics 10:133-140, 2000.
62. Statistics Canada. Available at http://www.statcan.ca/english/Pgdb/ popula.htm. Accessed March 22, 2005.
63. Tamatani S, Sasaki O, Takeuchi S, Fujii Y, Koike T, Tanaka R: Detection of delayed cerebral vasospasm, after rupture of intracranial aneurysms, by magnetic resonance angiography. Neurosurgery 40:748-753, 1997.
64. Tanus-Santos JE, Desai M, Flockhart DA: Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11:719-725, 2001.
65. Unterberg AW, Sakowitz OW, Sarrafzadeh AS, Benndorf G, Lanksch WR: Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 94:740-749, 2001.
66. U.S. Census Bureau. Available at http://factfinder.census.gov/. Accessed March 22, 2005.
67. Usui M, Saito N, Hoya K, Todo T: Vasospasm prevention with postoperative intrathecal thrombolytic therapy: A retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 34:235-244, 1994.
68. van der Voet M, Olson JM, Kuivaniemi H, Dudek DM, Skunca M, Ronkainen A, Niemela M, Jääskeläinen J, Hernesniemi JA, Helin K, Leinonen E, Biswas M, Tromp G: Intracranial aneurysms in Finnish families: Confirmation of linkage and refinement of the interval to chromosome 19q13.3. Am J Hum Genet 74:564-571, 2004.
69. Vora YY, Suarez-Almazor M, Steinke DE, Martin ML, Findlay JM: Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 44:1237-1247, 1999.
70. Wurm G, Tomancok B, Nussbaumer K, Adelwohrer C, Holl K: Reduction of ischemic sequelae following spontaneous subarachnoid hemorrhage: A double-blind, randomized comparison of enoxaparin versus placebo. Clin Neurol Neurosurg 106:97-103, 2004.
71. Yanamoto H, Kikuchi H, Sato M, Shimizu Y, Yoneda S, Okamoto S: Therapeutic trial of cerebral vasospasm with the serine protease inhibitor, FUT-175, administered in the acute stage after subarachnoid hemorrhage. Neurosurgery 30:358-363, 1992.
72. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y, Saito Y, Miyamoto Y, Nakao K: A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 103:65-69, 1998.
73. Ziche M, Morbidelli L: Nitric oxide and angiogenesis. J Neurooncol 50:139-148, 2000.